Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Biolinerx Announced First Patient Dosed In Randomized Phase 2 Combination Clinical Trial Evaluating Motixafortide In First-line Pancreatic Cancer

Author: Charles Gross | February 28, 2024 08:14am

Posted In: BLRX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist